| Document |
Document Title |
|
WO/2013/033604 |
This disclosure relates to the production of butanols using thermophilic microorganisms.
|
|
WO/2013/029106 |
A method for detecting H2S produced by a microorganism comprising providing a thiazine dye to a culture medium; culturing a microorganism in the culture medium; and detecting H2S produced by the microorganism by determining a colour chan...
|
|
WO/2013/032158 |
The present invention relates to a method which makes use of either Ang1 (angiopoietin 1) or COMP-Ang1 (cartilage oligomeric matrix protein-angiopoietin 1), which regulate the differentiation mechanism of stem cells, so as to induce spec...
|
|
WO/2013/031975 |
The present invention relates to: a method for producing an intermediate for the biosynthesis of fusicoccin A; an enzyme which can be used in the production method; and a product of the enzyme. According to the present invention, it beco...
|
|
WO/2013/032693 |
A species of Burkholderia sp with no known pathogenicity to vertebrates but with pesticidal activity (e.g., plants, algae, arachnids, insects, fungi, weeds and nematodes) as well as methods for controlling algae using said species of Bur...
|
|
WO/2013/033646 |
The present disclosure provides isolated phototrophic cells for producing hydrogen and methods for thereof. The methods involve inducing endo-hydrogenase expression in the phototrophic cells through the use of a regulatable promoter and ...
|
|
WO/2013/033278 |
This invention relates to apparatuses and methods for the reduction of carbon dioxide emissions resulting from combustion using a bioreactor that includes methanogenic bacteria or genetically modified algae.
|
|
WO/2013/029176 |
Provided are isolated cellobiohydrolases comprising a modified Glycoside Hydrolase (GH) Family 7 catalytic domain, a GH Family 7 catalytic domain and a modified Family carbohydrate binding module (CBM), or both a modified Family 7 cataly...
|
|
WO/2013/030329 |
The present invention relates to a genetically modified yeast cell comprising: - at least one recombinant promoter operably linked to at least one gene encoding a polypeptide or protein supporting the biosynthesis of polypeptides or prot...
|
|
WO/2013/032693 |
A species of Burkholderia sp with no known pathogenicity to vertebrates but with pesticidal activity (e.g., plants, algae, arachnids, insects, fungi, weeds and nematodes) as well as methods for controlling algae using said species of Bur...
|
|
WO/2013/030340 |
The invention relates to a method and to a device for feeding gases or gas mixtures into a liquid, suspension, or emulsion in a reactor in a specific manner. According to the invention, gases or gas mixtures are fed into a liquid, suspen...
|
|
WO/2013/032189 |
The present invention relates to a fermented vegetable oil, to a method for preparing the oil, and to a composition including the oil. More particularly, the present invention relates to a technique for providing a fermented vegetable oi...
|
|
WO/2013/032158 |
The present invention relates to a method which makes use of either Ang1 (angiopoietin 1) or COMP-Ang1 (cartilage oligomeric matrix protein-angiopoietin 1), which regulate the differentiation mechanism of stem cells, so as to induce spec...
|
|
WO/2013/032189 |
The present invention relates to a fermented vegetable oil, to a method for preparing the oil, and to a composition including the oil. More particularly, the present invention relates to a technique for providing a fermented vegetable oi...
|
|
WO/2013/028928 |
The present invention relates to recombinant filamentous fungal host cells producing cellulolytic enzyme compositions and methods of producing and using the compositions.
|
|
WO/2013/026887 |
The present invention pertains to microorganisms of the species Bacteroides xylanisolvens expressing a core-1 antigen on their surface. These microorganisms are in particular useful for the prophylaxis and treatment of core-1 positive di...
|
|
WO/2013/029027 |
The invention provides metabolically enhanced cells in a cell culture that express a characteristic that enables a separation of the metabolically enhanced cells from other cells that do not express the characteristic. The invention furt...
|
|
WO/2013/027802 |
Anti-DDR1 antibodies were produced and the anti-tumor activities of the anti-DDR1 antibodies were studied extensively. As a result, it was found that an antibody capable of binding to a Stalk region among amino acid sequences for human D...
|
|
WO/2013/028816 |
A concentrated bioenzymatic cleaning product is provided which maintains a homogenous composition under static conditions and does not require shaking or mixing prior to dilution. The concentrated bioenzymatic cleaning product includes b...
|
|
WO/2013/026385 |
Disclosed in the present invention is a preparation method for quadrivalent meningococcal polysaccharide vaccine, comprising the following steps: strains are selected; seed lots are established and passaged; vaccine stock solutions are p...
|
|
WO/2013/028030 |
The present invention relates to a method for separating and purifying 1,4-diaminobutane of a high purity and high yield from a 1,4-diaminobutane fermented solution, produced by fermentation, through the steps of strain separation, salt ...
|
|
WO/2013/027709 |
This transformant is obtained by introducing, to a host coryneform bacterium, at least one of the DNAs (a), (b), and (c): (a) a DNA, or an analog thereof, obtained by introducing, to a DNA that encodes an acetohydroxy acid synthase deriv...
|
|
WO/2013/028727 |
Systems are provided with varying flow chamber configurations which acoustically agglomerate microorganisms such as algae for separation from a host fluid such as water. Related apparatus, systems, techniques and articles are also descri...
|
|
WO/2013/028030 |
The present invention relates to a method for separating and purifying 1,4-diaminobutane of a high purity and high yield from a 1,4-diaminobutane fermented solution, produced by fermentation, through the steps of strain separation, salt ...
|
|
WO/2013/029013 |
The disclosure relates to enzyme producing Bacillus strains that provide benefits to animals and methods of using these strains. In one embodiment, the disclosure relates compositions comprising the enzyme producing Bacillus strains. In ...
|
|
WO/2013/028635 |
Methods for producing heterologous multi-subunit proteins in transformed cells are disclosed. In particular, the present disclosure provides improved methods of producing multi-subunit proteins, including antibodies and other multi-subun...
|
|
WO/2013/024178 |
The present invention relates to a process for providing purified bacteria-containing concentrates, comprising at least the steps of adding an aqueous solution to a first bacteria- containing concentrate to provide a bacteria-containing ...
|
|
WO/2013/024527 |
Provided are a method for producing alkane and a recombinant microorganism which offer excellent alkane production performance in a reaction system for synthesizing alkane by alkane synthase activity. The present invention considerably i...
|
|
WO/2013/023786 |
The present invention relates to a novel microalgal strain whose lipid production has been enhanced compared to the wild type. Said lipid content produced by the microalgae of the invention is particularly rich in neutral lipids. The pre...
|
|
WO/2013/024196 |
The present invention describes bacterial strains of the species B. subtilis CECT 7968, CECT 7969 and NCIMB 42026, that are capable of expressing the heterologous synthetic mutated Z. mobilis pdc and adhB, E. coli 'tesA and Acinetobacter...
|
|
WO/2013/025972 |
Disclosed are yeast-based immunotherapeutic compositions comprising mucin- 1 (MUCl), as well as methods for the prevention and/or treatment of cancers characterized by the expression or overexpression of mucin- 1 (MUCl).
|
|
WO/2013/025286 |
Recombinant bacteria having an improved ability to utilize sucrose are provided. These recombinant bacteria have nucleotide sequences encoding sucrose utilization polypeptides integrated into their genome between the yihP gene or its hom...
|
|
WO/2013/024904 |
The present invention provides a method for producing L-amino acid using a bacterium belonging to the family Enterobacteriaceae, particularly a motile bacterium belonging to the genus Escherichia, Enterobacter or Pantoea, wherein the bac...
|
|
WO/2013/024947 |
The present invention relates to a microorganism having an enhanced L-valine productivity and a method for producing L-valine using the same. More particularly, the present invention relates to a Corynebacterium glutamicum mutant strain ...
|
|
WO/2013/026033 |
The disclosure relates to strains, compositions and methods for detoxifying a mycotoxin. In another embodiment, the disclosure relates to strains, compositions and methods for alleviating the gastrointestinal inflammatory response result...
|
|
WO/2013/025248 |
Eukaryotic protein-coding messenger RNAs and non-coding microRNAs are naturally transcribed by type II RNA polymerases (pol-2) but not prokaryotic RNA polymerases. As a result, current eukaryotic RNA and protein production is performed e...
|
|
WO/2013/023557 |
Provided in the present invention is a humanized monoclone antibody of macrophage inhibition factor 1; the amino acid sequences of the heavy chain variable regions CDR1, CDR2 and CDR3 of the antibody are shown as SEQ ID NO: 1, 2 and 3, r...
|
|
WO/2013/026054 |
The method described herein provides a novel platform utilizing yeast as a biological non-host system to express and assemble whole viruses for use as attenuated or killed vaccines.
|
|
WO/2013/024816 |
In the present invention, raw water (W) that contains microalgae is introduced into a pH adjustment flocculation tank (1), and a soluble metal salt for generating a sparingly-soluble hydroxide is added and the pH is adjusted to a predete...
|
|
WO/2013/023391 |
Disclosed are a Pseudonocardia sp. and a method for preparing deoxynyboquinone by the same. Pseudonocardia sp. SCSIO 01299 was deposited on July 18, 2011, at the China Center for Type Culture Collection (CCTCC), address: Wuhan University...
|
|
WO/2013/020189 |
The present invention relates to the simultaneous production of thanase and phytase from waste castor-oil-plant cake in solid-state fermentation with Paecilomyces variotii, and also the reduction in the concentration of castor oil after ...
|
|
WO/2013/020350 |
The present invention is an Empedobacter brevis pesticide which can lead to plant pests dying of disease rapidly and a preparation method thereof. The Empedobacter brevis pesticide includes an Empedobacter brevis suspension and an Empedo...
|
|
WO/2013/021138 |
The invention relates to yeast flakes enriched with vitamin D2, to compositions including said flakes, and to the uses thereof, as well as to a method for preparing yeast flakes enriched with vitamin D2 and to the device for implementing...
|
|
WO/2013/022881 |
Recombinant microorganisms, plants, and plant cells are disclosed that have been engineered to express a mutant AROM polypeptide and/or mutant catechol-O-methyltransferase polypeptide alone or in combination with one or more vanillin bio...
|
|
WO/2013/023198 |
The invention provides methods of detecting bacteria in fluids, including blood, platelets and other blood products for transfusion, and urine. The methods are based on lysing the bacteria to release ATP and detecting the ATP. Eukaryotic...
|
|
WO/2013/021957 |
Provided are: a novel lactic acid bacterium strain which can inhibit the production of any volatile sulfur compound by a mouth bacterium, does not have a caries-producing property, does not cause infective endocarditis, and is safe in an...
|
|
WO/2013/022083 |
[Problem] To provide: an anti-human NGF antibody which is reduced in the influence on fetuses and the risk of adverse side effects including thrombosis while keeping a high neutralizing activity, and which has excellent safety, or an ant...
|
|
WO/2013/021811 |
The purpose of the present invention is to enable the production of an yeast fungus having a novel trait, which cannot be obtained so far, in a steady and systematic manner on the basis of a technique for overlapping an arbitrary genomic...
|
|
WO/2013/022332 |
The invention relates to a method for producing a mixture for bioremediation, containing nixtamalized maize flour and a composition based on bacteria of the Bacillus genus. This mixture is used for bioremediation and bioagumentation invo...
|
|
WO/2013/020188 |
The present invention comprises the production of culture media capable of making simultaneous production of two enzymes - phytase and thanase - viable, by means of solid fermentation on orange bagasse using the fungus Paecilomyces vario...
|
